Primecap Management’s SOLAZYME INC COM STK (DE) SZYM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q2 | – | Sell |
-12,057,284
| Closed | -$24.5M | – | 277 |
|
|
2016
Q1 | $24.5M | Sell |
12,057,284
-5,800
| -0% | -$10.3K | 0.03% | 195 |
|
|
2015
Q4 | $29.9M | Buy |
12,063,084
+55,850
| +0.5% | +$166K | 0.03% | 190 |
|
|
2015
Q3 | $31.2M | Buy |
12,007,234
+35,025
| +0.3% | +$91.3K | 0.03% | 187 |
|
|
2015
Q2 | $37.6M | Buy |
11,972,209
+80,500
| +0.7% | +$276K | 0.04% | 185 |
|
|
2015
Q1 | $34M | Sell |
11,891,709
-1,000
| -0% | -$2.56K | 0.03% | 182 |
|
|
2014
Q4 | $30.7M | Buy |
11,892,709
+2,145,900
| +22% | +$9.39M | 0.03% | 188 |
|
|
2014
Q3 | $72.7M | Buy |
9,746,809
+628,400
| +7% | +$5.87M | 0.08% | 144 |
|
|
2014
Q2 | $107M | Buy |
9,118,409
+937,220
| +11% | +$9.99M | 0.12% | 121 |
|
|
2014
Q1 | $95M | Buy |
8,181,189
+1,559,076
| +24% | +$18.3M | 0.11% | 129 |
|
|
2013
Q4 | $72.1M | Buy |
6,622,113
+3,810,100
| +135% | +$37.5M | 0.09% | 139 |
|
|
2013
Q3 | $30.3M | Buy |
2,812,013
+834,513
| +42% | +$9.5M | 0.04% | 174 |
|
|
2013
Q2 | $23.2M | Buy |
+1,977,500
| New | +$19.8M | 0.03% | 177 |
|
Primecap Management's SZYM Position: Q2 2016 in Review
Primecap Management sold out of SOLAZYME INC COM STK (DE) (SZYM) in Q2 2016, closing a stake of 12,057,284 shares — an estimated $24.5M sold.
Primecap Management first reported a position in SZYM in Q2 2013 and held it in 12 quarters. The position peaked at $107M in Q2 2014. 0 funds tracked by Wall St. Rank hold SZYM as of Q2 2016.
- Primecap Management reported no remaining SOLAZYME INC COM STK (DE) position as of Q2 2016 after selling out during the quarter.
- Primecap Management sold 12,057,284 SOLAZYME INC COM STK (DE) shares in Q2 2016, an estimated $24.5M.
- Primecap Management first reported a position in SOLAZYME INC COM STK (DE) in Q2 2013 and held it in 12 quarters.
- Primecap Management's SOLAZYME INC COM STK (DE) position peaked at $107M in Q2 2014.
- 0 funds tracked by Wall St. Rank held SOLAZYME INC COM STK (DE) as of Q2 2016.
Based on Primecap Management's 13F filing for Q2 2016, filed 12 Aug 2016.